Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited (LDXHF) Financial Performance & Income Statement Overview
Explore the financials of Lumos Diagnostics Holdings Limited (LDXHF), including yearly and quarterly data on income, cash flow, and balance sheets.
Lumos Diagnostics Holdings Limited (LDXHF) Income Statement & Financial Overview
Review Lumos Diagnostics Holdings Limited LDXHF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.18M | $4.18M | $1.38M | $1.38M |
| Cost of Revenue | $1.62M | $1.62M | $665500.00 | $665500.00 |
| Gross Profit | $2.56M | $2.56M | $717500.00 | $717500.00 |
| Gross Profit Ratio | $0.61 | $0.61 | $0.52 | $0.52 |
| R&D Expenses | $20500.00 | $20500.00 | $55000.00 | $55000.00 |
| SG&A Expenses | $2.90M | $2.90M | $2.85M | $2.85M |
| Operating Expenses | $2.92M | $2.92M | $2.91M | $3.52M |
| Total Costs & Expenses | $4.54M | $4.54M | $3.57M | $4.19M |
| Interest Income | $0.00 | $0.00 | $401000.00 | $401000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $171250.00 | $322166.00 | $624000.00 | $624000.00 |
| EBITDA | -$842250.00 | -$691334.00 | -$2.19M | -$2.19M |
| EBITDA Ratio | -$0.20 | -$0.17 | -$1.58 | -$1.58 |
| Operating Income | -$354000.00 | -$354000.00 | -$2.19M | -$2.81M |
| Operating Income Ratio | -$0.08 | -$0.08 | -$1.58 | -$2.04 |
| Other Income/Expenses (Net) | -$735500.00 | -$735500.00 | -$1.02M | -$391500.00 |
| Income Before Tax | -$1.09M | -$1.09M | -$3.21M | -$3.21M |
| Income Before Tax Ratio | -$0.26 | -$0.26 | -$2.32 | -$2.32 |
| Income Tax Expense | $0.00 | -$659500.00 | -$624000.00 | $0.00 |
| Net Income | -$1.09M | -$1.09M | -$3.21M | -$3.21M |
| Net Income Ratio | -$0.26 | -$0.26 | -$2.32 | -$2.32 |
| EPS | -$0.002 | -$0.002 | -$0.007 | -$0.007 |
| Diluted EPS | -$0.002 | -$0.002 | -$0.007 | -$0.007 |
| Weighted Avg Shares Outstanding | $482.08M | $482.08M | $444.48M | $444.48M |
| Weighted Avg Shares Outstanding (Diluted) | $481.94M | $481.94M | $444.45M | $444.45M |
Over the last four quarters, Lumos Diagnostics Holdings Limited achieved steady financial progress, growing revenue from $1.38M in Q1 2024 to $4.18M in Q4 2024. Gross profit stayed firm with margins at 61% in Q4 2024 versus 52% in Q1 2024. Operating income totaled -$354000.00 in Q4 2024, maintaining a -8% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$842250.00. Net income rose to -$1.09M, with EPS at -$0.002. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan